Miaomiao Xi (Rui Lin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Signaling Pathway

Ischemia Reperfusion Injury

Cognitive Decline

Top Venues

The Journal of pharmacy and pharmacology

The American journal of Chinese medicine

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Meina Zhao, Fei Mu, Miaomiao Xi, Kai Gao, Wei Zhang, Xingru Tao, Dong Xu, Jing-Wen Wang
Chinese Medicine-Derived Salvianolic Acid B for Disease Therapy: A Scientometric Study. The American journal of Chinese medicine (2024)
Fei Mu, Jiaxin Zhao, Meina Zhao, Rui Lin, Kedi Liu, Shi Zhao, Xingru Tao, Weihong Li, Qi Dai, Miaomiao Xi, Haifeng Tang, Jing-Wen Wang
Styrax (Liquidambar orientalis Mill.) promotes mitochondrial function and reduces cardiac damage following myocardial ischemic injury: the role of the AMPK-PGC1α signaling pathway. The Journal of pharmacy and pharmacology (2023)
Miaomiao Xi, Fei Mu, Yao Li, Jialin Duan, Meina Zhao, Yue Guan, Kedi Liu, Yang Bai, Aidong Wen, Peifeng Wei, Jing-Wen Wang, Miao-Miao Xi
Salvia miltiorrhiza and the Volatile of Dalbergia odorifera Attenuate Chronic Myocardial Ischemia Injury in a Pig Model: A Metabonomic Approach for the Mechanism Study. Oxidative medicine and cellular longevity 2021 (2021)
Xiaoxiao Wu, Meiyou Liu, Guo Wei, Yue Guan, Jialin Duan, Miaomiao Xi, Jingwen Wang
Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3α signalling pathway. The Journal of pharmacy and pharmacology 72 (5) (2020)